论文部分内容阅读
为评估吲哚靛青绿潴留率对预测肝癌手术风险的价值，对１６１例经剖腹探查的肝癌病人作术前检测吲哚靛青绿１５分钟潴留率（ＩＣＧＲ１５）及常规肝功能试验。根据术后肝功能代偿情况分为三组：肝功能代偿良好组１０９例，轻度不全组３５例，重度不全组１７例。结果：三组常规肝功能试验值差异均无显著性意义；ＩＣＧＲ１５值三组差异有非常显著性意义。根据ＩＣＧＲ１５值分为Ａ、Ｂ、Ｃ三组，Ａ组小于１０．０％；Ｂ组为１０．０％～２０．０％；Ｃ组大于２０．０％。Ａ、Ｂ、和Ｃ三组肝功能不全发生率分别为１１．６％、３０．９％及８１．０％，其差异有非常显著性意义。结果提示ＩＣＧＲ１５是评估肝癌患者术前肝储备功能较好的指标，可用于预测肝癌手术的风险性。
To assess the value of Indocyanine Green retention rate for predicting the risk of liver cancer surgery, 161 preoperative liver cancer patients undergoing exploratory laparotomy were assessed for preoperative ICU 15 and routine liver function tests. According to the postoperative liver function compensation, they were divided into three groups: 109 patients with good liver function compensation, 35 patients with mild insufficiency, and 17 patients with severe insufficiency. Results: There was no significant difference in the three groups of routine liver function test values; ICGR15 values had very significant differences in the three groups. According to the ICGR15 value, it was divided into three groups: A, B, and C. The A group was less than 10.0%; the B group was 10.0% to 20.0%; and the C group was greater than 20.0%. The incidence of hepatic insufficiency in groups A, B, and C was 11.6%, 30.9%, and 81.0%, respectively, and the difference was highly significant. The results suggest that ICGR15 is a good indicator of preoperative liver reserve function in liver cancer patients and can be used to predict the risk of liver cancer surgery.